Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
gap decrease » gain decreased (Expand Search), mean decrease (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
gap decrease » gain decreased (Expand Search), mean decrease (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
3181
Comparison of 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescription.
Published 2024Subjects: “…fluoroquinolone shares decreased…”
-
3182
UTI diagnoses by sex and physician specialty (2013–2019).
Published 2024Subjects: “…fluoroquinolone shares decreased…”
-
3183
Arrangement of PHC facilities in a woreda NoCs.
Published 2025“…The <i>"Improve Primary Health Care Service Delivery (IPHCSD)"</i> project, implemented by JSI and Amref Health Africa since April 2022, seeks to address these gaps through a Networks of Care (NoCs) approach. …”
-
3184
-
3185
-
3186
Table2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX
Published 2024“…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
-
3187
Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX
Published 2024“…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
-
3188
-
3189
(A) Changes of left ventricular ejection fraction over time in Roxadustat and ESAs groups.
Published 2025Subjects: -
3190
-
3191
Comparison of phenotypes between adult control and <i>aP2-Drp1</i><sup>f/f</sup> mice.
Published 2024Subjects: -
3192
-
3193
-
3194
-
3195
-
3196
-
3197
-
3198
-
3199
PP1/PP2A does not dephosphorylate pS295 <i>in vitro</i>.
Published 2024“…The decrease of phosphorylated GSK3β (pGSK3β(S9)) was completely suppressed by the PP1/PP2A inhibitor calyculin A. …”
-
3200